dc.contributor.author |
Yamey, Gavin |
|
dc.contributor.author |
Garcia Funegra, Patricia Jannet |
|
dc.contributor.author |
Hassan, Fatima |
|
dc.contributor.author |
Mao, Wenhui |
|
dc.contributor.author |
McDade, Kaci Kennedy |
|
dc.contributor.author |
Pai, Madhukar |
|
dc.contributor.author |
Saha, Senjuti |
|
dc.contributor.author |
Schellekens, Philip |
|
dc.contributor.author |
Taylor, Andrea |
|
dc.contributor.author |
Udayakumar, Krishna |
|
dc.date.accessioned |
2022-04-26T17:26:49Z |
|
dc.date.available |
2022-04-26T17:26:49Z |
|
dc.date.issued |
2022 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/11606 |
|
dc.description.abstract |
During the covid-19 pandemic, we have seen the best of international collective action and its limits. Global scientific cooperation drove the development of safe, highly effective covid-19 vaccines in under one year.1 Yet we have also witnessed global vaccine inequity,2 in which low and middle income countries have “limited supply and limited vaccine brand options. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
BMJ Publishing Group |
|
dc.relation.ispartofseries |
BMJ |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
COVID-19 |
en_US |
dc.subject |
Vaccine Equity |
en_US |
dc.title |
It is not too late to achieve global covid-19 vaccine equity |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1136/bmj-2022-070650 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.03.05 |
|
dc.relation.issn |
1756-1833 |
|